These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30384349)

  • 41. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanoemulsion: An Advanced Vehicle For Efficient Drug Delivery.
    Ali A; Ansari VA; Ahmad U; Akhtar J; Jahan A
    Drug Res (Stuttg); 2017 Nov; 67(11):617-631. PubMed ID: 28738427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of a 2-step agglomeration process performed in a rotary processor using polyethylene glycol solutions as the primary binder liquid.
    Kristensen J
    AAPS PharmSciTech; 2006 Oct; 7(4):89. PubMed ID: 17233541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interdependence of Dosage Form Microstructure and Performance.
    Axel Zeitler J; Rades T
    Pharm Res; 2017 May; 34(5):887-889. PubMed ID: 28299534
    [No Abstract]   [Full Text] [Related]  

  • 45. In vitro hemolysis: guidance for the pharmaceutical scientist.
    Amin K; Dannenfelser RM
    J Pharm Sci; 2006 Jun; 95(6):1173-6. PubMed ID: 16639718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.
    Pouton CW; Porter CJ
    Adv Drug Deliv Rev; 2008 Mar; 60(6):625-37. PubMed ID: 18068260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclodextrin complexes: Perspective from drug delivery and formulation.
    Jacob S; Nair AB
    Drug Dev Res; 2018 Aug; 79(5):201-217. PubMed ID: 30188584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins.
    Allen LV
    Int J Pharm Compd; 2022; 26(2):118-126. PubMed ID: 35413011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of excipients on transporter mediated absorption.
    Goole J; Lindley DJ; Roth W; Carl SM; Amighi K; Kauffmann JM; Knipp GT
    Int J Pharm; 2010 Jun; 393(1-2):17-31. PubMed ID: 20417699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diverse approaches for the enhancement of oral drug bioavailability.
    Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
    Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basics of compounding: Tips and hints, part 2: compounding with solutions, suspensions, emulsions, and lotions.
    Allen LV
    Int J Pharm Compd; 2014; 18(2):137-8. PubMed ID: 24881118
    [No Abstract]   [Full Text] [Related]  

  • 52. The technologies used for developing orally disintegrating tablets: a review.
    Badgujar BP; Mundada AS
    Acta Pharm; 2011 Jun; 61(2):117-39. PubMed ID: 21684842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hospital Compounding in Nigeria: A Review of Needs, Practice, and Suggestions for Pharmaceutical Dispensing Ciurriculum Development.
    Orubu ESF; Patani BO; Arhewoh MI
    Int J Pharm Compd; 2021; 25(6):475-481. PubMed ID: 34807842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Updating formulations for compounded oral liquid medications in a university health system.
    Stumpf JL; Leja N; Ciarkowski SL; Salah S; Schaeffler KL
    Am J Health Syst Pharm; 2018 Sep; 75(18):1394-1398. PubMed ID: 30006436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mixing and compatibility guide for commonly used aerosolized medications.
    Burchett DK; Darko W; Zahra J; Noviasky J; Probst L; Smith A
    Am J Health Syst Pharm; 2010 Feb; 67(3):227-30. PubMed ID: 20101066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hydrophilic Ready-to-use Vehicles and Compounded Topical Medications.
    Spennacchio A; Lacassia C; Lopalco A; Lopedota AA; la Forgia FM; Fontana S; Franco M; Denora N
    Int J Pharm Compd; 2024; 28(2):138-145. PubMed ID: 38604140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Standardization of compounded oral liquids for pediatric patients in Michigan.
    Engels MJ; Ciarkowski SL; Rood J; Wang B; Wagenknecht LD; Dickinson CJ; Stevenson JG
    Am J Health Syst Pharm; 2016 Jul; 73(13):981-90. PubMed ID: 27325879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pediatric drug development: formulation considerations.
    Ali AA; Charoo NA; Abdallah DB
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel prospective in colon specific drug delivery system.
    Bansal V; Malviya R; Malaviya T; Sharma PK
    Polim Med; 2014; 44(2):109-18. PubMed ID: 24967782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perceptions of pharmaceutical care among pharmacists offering compounding services.
    Yancey V; Yakimo R; Perry A; McPherson TB
    J Am Pharm Assoc (2003); 2008; 48(4):508-14. PubMed ID: 18653427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.